Governor signs GA HB 235 into law

Article

The new Georgia law allows ODs to prescribe steroids, hydracodone, and all medications using any distribution method except surgical or injectable, plus requires all ODs to take CE regardless of age.

Atlanta, GA-Georgia governor Nathan Deal (R) yesterday signed into law HB 235. The new law is effective immediately and:
• Allows optometrists to prescribe corticosteroids for up to 14 days.
• Allows optometrists to prescribe hydrocodone for up to 48 hours regardless of any changes to federal reclassification of the medication.
• Allows optometrists to prescribe all medication using any appropriate distribution method except surgical or injectable, including any new vehicles to administer medications, such as nasal sprays, contact lenses, etc.
• Requires all optometrists to take continuing education regardless of age.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
© 2025 MJH Life Sciences

All rights reserved.